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Abstract
Introduction: Schizophrenia is frequently associated with a 
debilitating course and prominent impairment in social and 
occupational functioning. Although the criteria for classification 
into stages have not been defined in the literature, illness 
duration and functioning seem to be good candidates.
Objective: To compare functioning of patients with schizophrenia 
at different stages of the disease (early vs. late) and healthy sex- 
and age-matched controls.
Methods: This double-blinded, case-controlled study included 
79 individuals: 23 patients with schizophrenia diagnosed up to 5 
years earlier; 19 patients with schizophrenia diagnosed at least 
20 years earlier; and healthy matched controls. Diagnoses were 
established using the Structured Clinical Interview for Diagnostic 
and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) 
Axis I Disorder. Functioning was assessed using the Functioning 
Assessment Short Test (FAST). 
Results: Patients in the early stage had significantly higher 
scores than healthy controls in total FAST and in autonomy, 
occupational functioning, cognitive functioning and interpersonal 
relationships. Individuals in the late stage had significantly 
poorer functioning than controls in all domains. The comparison 
of functioning between the two groups of patients revealed no 
significant differences, except in occupational functioning, in 
which late stage patients had a poorer performance.
Conclusion: Functioning impairment in schizophrenia tends to 
remain stable despite illness duration. Therefore, functioning 
should be effectively assessed at an early stage, as illness 
duration alone may not be the most reliable criterion to stage 
patients with schizophrenia.
Keywords: Cognition, functioning, psychosis, schizophrenia, 
staging.
Resumo
Introdução: A esquizofrenia está frequentemente associada a 
um curso debilitante e a um importante comprometimento no 
funcionamento social e ocupacional. Embora os critérios para 
classificação em diferentes estágios ainda não tenham sido 
definidos, a duração da doença e a funcionalidade têm sido 
apontadas como bons candidatos.
Objetivo: Comparar a funcionalidade de indivíduos com 
esquizofrenia no estágio inicial e final com controles saudáveis 
correspondentes em idade e sexo.
Métodos: Neste estudo caso-controle, duplo-cego, foram incluídos 
79 pacientes: 23 com diagnóstico de esquizofrenia feito até 5 anos 
atrás (estágio inicial); 19 diagnosticados há pelo menos 20 anos 
(estágio final); e controles saudáveis pareados. O diagnóstico foi 
estabelecido pela Entrevista Clínica Estruturada para Transtornos 
do Eixo I do Manual Diagnóstico e Estatístico de Transtornos 
Mentais, 4ª edição (DSM-IV). A funcionalidade foi avaliada através 
da escala Teste Breve de Avaliação Funcional (FAST).
Resultados: Os pacientes em estágio inicial tiveram escores 
significativamente maiores do que controles saudáveis na 
escala FAST (escore total e domínios autonomia, funcionamento 
ocupacional, funcionamento cognitivo e relações interpessoais). 
Os indivíduos em estágio final apresentaram funcionalidade pior 
que os controles em todos os domínios. A comparação entre os 
dois grupos não mostrou diferenças, exceto no funcionamento 
ocupacional, em que os pacientes em estágio final apresentaram 
um desempenho pior.
Conclusão: O prejuízo da funcionalidade na esquizofrenia 
tende a permanecer estável ao longo da doença. Portanto, a 
funcionalidade deve ser avaliada nos estágios iniciais da doença, 
já que a duração da doença por si só pode não ser o critério mais 
confiável para definir o estágio de pacientes com esquizofrenia.
Descritores: Cognição, funcionalidade, psicose, esquizofrenia, 
estadiamento.
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Introduction
Functioning is a complex concept involving several 
different domains, such as the capacity to work, study 
and live independently, as well as recreational and social 
capabilities.1 Patients with schizophrenia (SZ) have marked 
impairments in psychosocial functioning across multiple 
domains: independent living, interpersonal relationships, 
occupational and educational achievement, recreational 
enjoyment and sexual activity.2 Impairment begins in the 
early stages (ES) of the disease, and may continue for 
prolonged periods or result in sustained disability, with high 
personal suffering and indirect costs to society.2
The clinimetric concept of staging in SZ was 
introduced by Fava & Kellner in 1993, and an increasing 
body of research has supported the existence of 
stages in the longitudinal development of SZ.3 Staging 
systems have been constructed to refine diagnoses 
and clarify the biological basis of SZ, as well as to 
support the development of effective treatments that 
reduce or prevent progression to more advanced SZ 
phases.4,5 However, most studies have concentrated on 
symptom improvement and illness duration, with much 
less attention being paid to recovery of psychosocial 
functioning, although functioning impairment may be 
more debilitating and long-lasting than the positive 
symptoms that mark the onset of the illness.6 
Furthermore, studies have found that psychosocial 
functioning impairment is not significantly different 
between patients with a first episode and those with 
multiple episodes, which suggests that an early and 
effective psychometric instrument should be used to 
assess psychosocial functioning in these patients.1,7
Optimum care of individuals with SZ is heterogeneous, 
as it should include a personalized approach best fitted 
to relieve symptoms, restore functioning and prevent 
further illness progression. To improve treatment and 
maximize recovery,2 studies should investigate how and 
if these psychopathological dimensions (symptoms and 
functioning) correlate.
However, specific psychometric domain scales remain 
scarce. Most methods to assess functioning are lengthy 
and do not fully investigate discrete rather than global 
psychosocial deficits, which severely limits their ability to 
assess functioning in populations of individuals with SZ. 
Examining differences in functioning between early stage 
(ES) and late stage (LS) patients may help identify risk 
factors for disease progression and potential treatment 
directions. In sum, knowing in which stage the patient 
is may help predict disease progression and prognosis, 
both of which may guide treatment.8
The Functioning Assessment Short Test (FAST) is 
a good psychometric scale to assess functioning in 
such scenarios. Although not comprehensive, FAST 
assesses the most relevant functioning domains and 
may, therefore, provide a reliable index of functioning. 
Its simplicity, availability and short duration also 
contribute to its popularity and applicability, in both 
clinical and research settings.9 Despite its potential, 
FAST has not been used to compare functioning 
between patients with SZ (ES vs. LS). This study 
compared psychosocial functioning between patients 
in ES and LS of overt SZ and a healthy control group. 
We hypothesized that individuals in the LS group might 
have worse functioning than healthy controls and 
individuals in the ES group in all the domains of the 
FAST scale and in its total score.
Methods
This study was approved by the Ethics Committee of 
Hospital de Clínicas de Porto Alegre, RS, Brazil (HCPA) 
(No. 10-0348). In accordance with the Declaration 
of Helsinki, all participants were informed about the 
procedure, and all provided written informed consent 
before enrollment. Forty-two stable outpatients with 
SZ and thirty-seven healthy controls matched for age, 
sex and level of education were recruited. This double-
blinded, case-controlled study included 23 patients in 
the ES, defined as the first 5 years after diagnosis, 19 
at LS, defined as at least 20 years after the diagnosis of 
SZ, and 19 and 18 matched controls. All patients met the 
Diagnostic and Statistical Manual of Mental Disorders, 4th 
edition (DSM-IV) criteria for SZ according to the Semi-
Structured Interview for DSM-IV (SCID). The control 
group comprised healthy volunteers with no history of 
psychiatric disorders and no first-degree relative with 
a history of a major psychiatric disorder, including 
dementia or mental retardation. All participants were 
at least 18 and no older than 60 years old. None had 
any neurological disease, brain tumor, thyroid disease, 
severe hepatic disease, severe cardiac disease or any 
other psychiatric diagnosis.
The psychopathological status of patients with SZ 
was assessed using the 18-item Brief Psychiatry Rating 
Scale (BPRS). The BPRS consists of an unstructured 
interview that includes the following 18 items: somatic 
concern, psychic anxiety, emotional withdrawal, 
conceptual disorganization, feelings of self-depreciation 
and guilt, somatic anxiety, specific motor disturbances, 
overly inflated self-esteem, depressive mood, 
hostility, suspiciousness, hallucinations, psychomotor 
retardation, uncooperativeness, unusual thought 
content, blunted or inappropriate affect, psychomotor 
agitation, and disorientation or confusion. The BPRS 
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used when multiple pairwise tests were performed. The 
level of significance was set at p < 0.05.
Results
Sample characteristics and comparisons between 
groups are shown in Table 1. Despite very different 
illness duration between the two groups, both had 
similar scores in BPRS, which indicated that their 
severity of symptoms was similar. Moreover, there were 
no differences in dose of antipsychotic in chlorpromazine 
equivalents (mean daily dose of antipsychotic in mg of 
chlorpromazine equivalent ± standard deviation: ES = 
400±194.24; LS = 624±203.01).
The analysis of functioning revealed significant 
difference in total FAST scores of patients in the ES and 
LS when compared with healthy controls; however, no 
differences were found when the ES and LS groups were 
compared to each other. The FAST scores for areas of 
functioning, such as autonomy, occupational functioning, 
cognitive functioning, financial issues, interpersonal 
relationships and leisure time, showed that the LS group 
had a poorer performance in all areas than controls. 
Nevertheless, there were no differences in financial 
issues and leisure time when the ES group was compared 
with controls. There were differences between ES and LS 
group scores in occupational functioning, but not in other 
areas of functioning.
was used to evaluate current symptoms and positive 
and negative dimensions.
Functioning was assessed using FAST, an instrument 
primarily developed to assess functional impairment 
in bipolar disorder10 and later structurally validated 
for SZ.11 The Brazilian FAST scale has 24 items to 
assess five specific domains of functioning: autonomy, 
occupational functioning, cognitive functioning, financial 
issues, and interpersonal relationships. The rater asks 
the patient about areas of difficulty in functioning and 
defines the score according to the following scale: (0) 
no difficulty, (1) mild difficulty, (2) moderate difficulty, 
and (3) severe difficulty.
Final scores are the sum of the scores for individual 
items in the preceding 15 days. A semi-structured manual 
is used to ensure uniform understanding of item scoring.11
Analysis was performed using the SPSS 18.0. 
In the LS group, 18 patients were using atypical 
antipsychotics, which was clozapine in 16 cases; the 
other four patients were using typical antipsychotics. 
In the ES group, 14 patients were using atypical 
antipsychotics, clozapine in seven cases; the other five 
patients were using typical antipsychotics. Demographic 
and clinical characteristics were analyzed using 
descriptive statistics: means and standard deviations, 
medians and interquartile ranges and percentages, 
when appropriate. Differences between groups were 
analyzed using a chi-square, the Mann-Whitney or a 
t test, as appropriate. The Bonferroni correction was 
ES SZ
(n = 23)
Controls
(n = 19) p
LS SZ
(n = 19)
Controls
(n = 18) p
ES x LS
p
Sex (male/female) 13/10 10/9 0.523* 15/4 13/5 0.714* -
Age in years 24.70±4.78 25.32±5.19 0.692† 47.47±3.41 46.89±4.28 0.650† -
Years of education 10.17±2.57 11.32±1.99 0.112† 10.26±3.23 10.39±3.22 0.906† -
Years of disease 2.52±1.83 - - 25.63±4.66 - - -
Antipsychotic daily dose, in mg of 
chlorpromazine equivalents
400±194.24 - - 624±203.01 - - -
BPRS total scores‡ 14 (10) - - 13 (9) - - -
FAST scores‡
Total 31 (22) 8.5 (10.25) < 0.0001s 34 (32) 7 (9) < 0.0001§ 0.328§
Autonomy 3 (6) 1 (2) 0.051§ 5 (6) 0.5 (2) < 0.0001§ 0.451§
Occupational functioning 10 (12) 0 (2) < 0.0001§ 15 (2) 0.5 (2) < 0.0001§ 0.017§
Cognitive functioning 6 (7) 3 (3) 0.027§ 6 (6) 4 (5) 0.004§ 1.00§
Financial issues 2 (3) 1 (2) 1.00§ 2 (4) 0 (0.25) 0.005§ 1.00§
Interpersonal relationships 6 (7) 1 (4) 0.001§ 6 (9) 0 (1.25) < 0.0001§ 1.00§
Leisure time 2 (3) 0 (2) 0.914§ 3 (4) 0 (2) 0.007§ 1.00§
Table 1 - Sample characteristics and comparisons between groups
Data presented as mean ± standard deviation, unless otherwise stated.
ES = patients in early stage, defined as up to 5 years after diagnosis of schizophrenia; FAST = Functioning Assessment Short Test; LS = patients in late stage, 
defined as at least 20 years after diagnosis of schizophrenia; SZ = schizophrenia.
* Chi-square; † t test; § Mann-Whitney test with Bonferroni correction for multiple pairwise test.
‡ Median (interquartile range).
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The findings of this study should be interpreted in 
light of some limitations. First, the sample size may 
be small to examine the impact of different predictors 
of functioning, such as the influence of different 
groups of symptoms, subtypes of SZ and the impact 
of medications. In addition, its cross-sectional design 
does not ensure that both groups are similar in all the 
variables involved in functioning. At the same time, the 
study has strengths, such as the inclusion of individuals 
without any medical and psychiatric comorbidities, which 
ruled out possible confounders.
Conclusion
Our findings indicate that illness duration alone is 
insufficient to classify individuals with SZ into stages 
because its effect on functioning is only partial. Furthermore, 
our data confirm previous evidence that functioning 
impairment tends to remain stable for a long time in most 
patients with SZ, and suggest that these patients should 
undergo early functioning assessment using effective 
psychometric instruments, such as the FAST scale.
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